Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Research
Molecular Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Retraction

Retraction: Protein Expression Profiling Identifies Cyclophilin A as a Molecular Target in Fhit-Mediated Tumor Suppression

DOI: 10.1158/1541-7786.MCR-21-0107 Published April 2021
  • Article
  • Info & Metrics
  • PDF
Loading

This article (1) has been retracted at the request of the corresponding author, K. Huebner. Examination of the data uncovered unexpected similarities in certain figures in this study. In addition, data in several figures from this study appear to overlap with data previously published by the authors in an earlier Oncogene article (2). This information was communicated to the corresponding author, who was not able to locate the original data from 2005, but who agreed that there were aberrations in the data that could not be explained. Specifically:

  • The same image seems to have been used to represent the GFP blot in Fig. 1Aa of this study (1) and the GFP blots in Fig. 1Ab of the Oncogene study (2).

  • The Ad-FHIT-wt GAPDH blot and the Ad-FHIT-Y114F GAPDH blot in Fig. 3A of this study (1) seem to match, respectively, the first six lanes of the A549 GAPDH blot and the last six lanes of the H1299 GAPDH blot in Fig. 1Ab of the Oncogene study (2).

  • In Figure 4C of this study (1):

    1. CDK4 blots in the first, third, and fourth columns seem to share a common origin.

    2. The p21CIP1 blots in the first, third, and fourth columns seem to share a common origin. There are differences in the intensity of signal between these three blots, but the similarity of the band patterns suggests that these may represent multiple different exposures from the same blot.

    3. The first two lanes of the p21CIP1 blot in the second column seem to match the first two lanes of the p21CIP1 blot in Fig. 4A. Similarly, the last two lanes of the p21CIP1 blot in the second column of Fig. 4C seem to match the fourth and fifth lanes of the p21CIP1 blot in Fig. 4A.

Given the potential issues outlined herein and that the original data are no longer available to correct the record, the corresponding author has requested that the study be retracted. The corresponding author apologizes to the scientific community and regrets any inconveniences or challenges resulting from the publication and subsequent retraction of this article.

Footnotes

  • Mol Cancer Res 2021;19:740

  • ©2021 American Association for Cancer Research.

References

  1. 1.↵
    1. Semba S,
    2. Huebner K
    . Protein expression profiling identifies cyclophilin A as a molecular target in Fhit-mediated tumor suppression. Mol Cancer Res 2006;4:529–38.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Semba S,
    2. Trapasso F,
    3. Fabbri M,
    4. McCorkell KA,
    5. Volinia S,
    6. Druck T,
    7. et al.
    Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential. Oncogene 2006;25:2860–72.
    OpenUrlCrossRefPubMed
Previous
Back to top
Molecular Cancer Research: 19 (4)
April 2021
Volume 19, Issue 4
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Retraction: Protein Expression Profiling Identifies Cyclophilin A as a Molecular Target in Fhit-Mediated Tumor Suppression
(Your Name) has forwarded a page to you from Molecular Cancer Research
(Your Name) thought you would be interested in this article in Molecular Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Retraction: Protein Expression Profiling Identifies Cyclophilin A as a Molecular Target in Fhit-Mediated Tumor Suppression
Mol Cancer Res April 1 2021 (19) (4) 740; DOI: 10.1158/1541-7786.MCR-21-0107

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Retraction: Protein Expression Profiling Identifies Cyclophilin A as a Molecular Target in Fhit-Mediated Tumor Suppression
Mol Cancer Res April 1 2021 (19) (4) 740; DOI: 10.1158/1541-7786.MCR-21-0107
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Retraction: Nek6 Mediates Human Cancer Cell Transformation and Is a Potential Cancer Therapeutic Target
  • Retraction: Role of Ribosomal Protein RPS2 in Controlling let-7a Expression in Human Prostate Cancer
Show more Retraction
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Rapid Impact Archive
  • Meeting Abstracts

Information for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCR

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Research
eISSN: 1557-3125
ISSN: 1541-7786

Advertisement